title: Model of bronchial allergic inflammation in the brown Norway rat. Pharmacological modulation.
abstract: Exposure of non-sensitized Brown Norway (BN) rats to a 10%-ovalbumin aerosol induced an increase in the number of neutrophils in the broncho-alveolar lavage (BAL) fluid 3 and 6 h later but with no change in number of cells at 24 h. When the BN rats were actively sensitized (i.m. injection of 10 mg/kg ovalbumin and i.p. injection of killed Bordetella pertussis) and exposed 12-14 days later to a 10%-ovalbumin aerosol there was an increase in the number of eosinophils in the BAL fluid, maximal 24-48 h after the anaphylactic reaction. The increase in the number of neutrophils in the bronchial lumen 3 and 6 h after the anaphylactic reaction was larger than that obtained in non-specific inflammation and in contrast to this was still present 24-48 h after ovalbumin exposure. In passively sensitized BN rats exposed to ovalbumin aerosol, no inflammation appeared in the BAL fluid 24 h after the anaphylactic reaction. Various drugs, administered twice, 5 min and 5 h after the anaphylactic reaction, have been evaluated for their effects on the 24-h inflammation obtained in actively sensitized rats. Dexamethasone acetate (0.08 mg/kg i.p.) and theophylline (50 mg/kg i.p.) decreased the number of eosinophils and neutrophils. Ketotifen fumarate (12.5 mg/kg), cetirizine dihydrochloride (12.5 mg/kg), salbutamol (2 mg/kg), disodium cromoglycate (50 mg/kg) all given intraperitoneally, reduced the number of eosinophils. Tioxamast decreased the number of eosinophils at 12.5 mg/kg i.p. and by the oral route.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Centre de Recherche Pierre Fabre, Castres, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Tarayre
authors.forename: M
authors.initials: M
authors.lastname: Aliaga
authors.forename: M
authors.initials: M
authors.lastname: Barbara
authors.forename: N
authors.initials: N
authors.lastname: Tisseyre
authors.forename: S
authors.initials: S
authors.lastname: Vieu
authors.forename: J
authors.initials: J
authors.lastname: Tisne-Versailles
mesh_terms: D000420:Albuterol / Q000627:therapeutic use; D000818:Animals; D001991:Bronchitis / Q000188:drug therapy* / Q000209:etiology; D003907:Dexamethasone / Q000627:therapeutic use; D004195:Disease Models, Animal; D007665:Ketotifen / Q000627:therapeutic use; D008297:Male; D010047:Ovalbumin / Q000276:immunology; D051381:Rats; D011914:Rats, Inbred BN; D012130:Respiratory Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D013806:Theophylline / Q000627:therapeutic use
chemical_list: D003907:Dexamethasone; D010047:Ovalbumin; D013806:Theophylline; D000420:Albuterol; D007665:Ketotifen